Literature DB >> 19858106

Modelling relative survival in the presence of incomplete data: a tutorial.

Ula Nur1, Lorraine G Shack, Bernard Rachet, James R Carpenter, Michel P Coleman.   

Abstract

BACKGROUND: Missing data frequently create problems in the analysis of population-based data sets, such as those collected by cancer registries. Restriction of analysis to records with complete data may yield inferences that are substantially different from those that would have been obtained had no data been missing. 'Naive' methods for handling missing data, such as restriction of the analysis to complete records or creation of a 'missing' category, have drawbacks that can invalidate the conclusions from the analysis. We offer a tutorial on modern methods for handling missing data in relative survival analysis.
METHODS: We estimated relative survival for 29 563 colorectal cancer patients who were diagnosed between 1997 and 2004 and registered in the North West Cancer Intelligence Service. The method of multiple imputation (MI) was applied to account for the common example of incomplete stage at diagnosis, under the missing at random (MAR) assumption. Multivariable regression with a generalized linear model and Poisson error structure was then used to estimate the excess hazard of death of the colorectal cancer patients, over and above the background mortality, adjusting for significant predictors of mortality.
RESULTS: Incomplete information on stage, morphology and grade meant that only 55% of the data could be included in the 'complete-case' analysis. All cases could be included after indicator method (IM) or MI method. Handling missing data by MI produced a significantly lower estimate of the excess mortality for stage, morphology and grade, with the largest reductions occurring for late-stage and high-grade tumours, when compared with the results of complete-case analysis.
CONCLUSION: In complete-case analysis, almost 50% of the information could not be included, and with the IM, all records with missing values for stage were combined into a single 'missing' category. We show that MI methods greatly improved the results by exploiting all the information in the incomplete records. This method also helped to ensure efficient inferences about survival were made from the multivariate regression analyses.

Entities:  

Mesh:

Year:  2009        PMID: 19858106     DOI: 10.1093/ije/dyp309

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  34 in total

1.  Insurance status, not race, is associated with mortality after an acute cardiovascular event in Maryland.

Authors:  Derek K Ng; Daniel J Brotman; Bryan Lau; J Hunter Young
Journal:  J Gen Intern Med       Date:  2012-10       Impact factor: 5.128

2.  Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.

Authors:  Antonio Tejera-Vaquerizo; Eduardo Nagore; Susana Puig; Caroline Robert; Philippe Saiag; Paula Martín-Cuevas; Elena Gallego; Enrique Herrera-Acosta; José Aguilera; Josep Malvehy; Cristina Carrera; Andrea Cavalcanti; Ramón Rull; Antonio Vilalta-Solsona; Emilie Lannoy; Celine Boutros; Naima Benannoune; Gorana Tomasic; Philippe Aegerte; Sergi Vidal-Sicart; Josep Palou; L Lúcia Alos; Celia Requena; Víctor Traves; Ángel Pla; Isidro Bolumar; Virtudes Soriano; Carlos Guillén; Enrique Herrera-Ceballos
Journal:  Eur J Cancer       Date:  2015-06-10       Impact factor: 9.162

3.  Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.

Authors:  Scott V Adams; Dennis J Ahnen; John A Baron; Peter T Campbell; Steven Gallinger; William M Grady; Loic LeMarchand; Noralane M Lindor; John D Potter; Polly A Newcomb
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

4.  Impact of comorbidities at diagnosis on prostate cancer treatment and survival.

Authors:  Katarina Luise Matthes; Manuela Limam; Giulia Pestoni; Leonhard Held; Dimitri Korol; Sabine Rohrmann
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-07       Impact factor: 4.553

5.  Social and Behavioural Determinants of the Difference in Survival among Older Adults in Japan and England.

Authors:  Jun Aida; Noriko Cable; Paola Zaninotto; Toru Tsuboya; Georgios Tsakos; Yusuke Matsuyama; Kanade Ito; Ken Osaka; Katsunori Kondo; Michael G Marmot; Richard G Watt
Journal:  Gerontology       Date:  2018-01-18       Impact factor: 5.140

6.  Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014.

Authors:  Xue Qin Yu; Paramita Dasgupta; Clare Kahn; Kou Kou; Susanna Cramb; Peter Baade
Journal:  Cancer Med       Date:  2021-05-06       Impact factor: 4.452

7.  Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer.

Authors:  G Lyratzopoulos; G A Abel; C H Brown; B A Rous; S A Vernon; M Roland; D C Greenberg
Journal:  Ann Oncol       Date:  2012-11-12       Impact factor: 32.976

8.  Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey.

Authors:  Georgios Lyratzopoulos; Gary A Abel; Sean McPhail; Richard D Neal; Gregory P Rubin
Journal:  BMJ Open       Date:  2013-06-24       Impact factor: 2.692

9.  Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.

Authors:  Veronika Fedirko; Elio Riboli; Anne Tjønneland; Pietro Ferrari; Anja Olsen; H Bas Bueno-de-Mesquita; Fränzel J B van Duijnhoven; Teresa Norat; Eugène H J M Jansen; Christina C Dahm; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Antoine Racine; Annekatrin Lukanova; Birgit Teucher; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Vassiliki Benetou; Dimitrios Trichopoulos; Sara Grioni; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Peter D Siersema; Petra H Peeters; Guri Skeie; Magritt Brustad; Maria-Dolores Chirlaque; Aurelio Barricarte; Jose Ramón Quirós; Maria José Sánchez; Miren Dorronsoro; Catalina Bonet; Richard Palmqvist; Göran Hallmans; Timothy J Key; Francesca Crowe; Kay-Tee Khaw; Nick Wareham; Isabelle Romieu; James McKay; Petra A Wark; Dora Romaguera; Mazda Jenab
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-25       Impact factor: 4.254

10.  Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.

Authors:  S Walters; C Maringe; J Butler; B Rachet; P Barrett-Lee; J Bergh; J Boyages; P Christiansen; M Lee; F Wärnberg; C Allemani; G Engholm; T Fornander; M L Gjerstorff; T B Johannesen; G Lawrence; C E McGahan; R Middleton; J Steward; E Tracey; D Turner; M A Richards; M P Coleman
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.